Form 4: Rocket Pharmaceuticals' General Counsel Sells Shares to Cover Tax Obligations

Martin Wilson, General Counsel of Rocket Pharmaceuticals, sold 3,222 shares of common stock to cover tax obligations related to vesting Restricted Stock Units.

Summary

• On February 21, 2025, Martin Wilson, the General Counsel of Rocket Pharmaceuticals, sold 3,222 shares of common stock at a price of $10.58 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
• Following the transaction, Wilson directly owns 150,696 shares of Rocket Pharmaceuticals' common stock.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sale of shares to cover taxes) and doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Sales of shares by company insiders are a common occurrence, often related to compensation and tax obligations. These transactions are closely monitored by investors for insights into management's perspective on the company's value and future prospects.

Stakeholder Impact

• The sale of shares by an insider could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact given the reason for the sale.

Key Dates